These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34197986)

  • 21. Effect of supersaturation on the oral bioavailability of paclitaxel/polymer amorphous solid dispersion.
    Miao L; Liang Y; Pan W; Gou J; Yin T; Zhang Y; He H; Tang X
    Drug Deliv Transl Res; 2019 Feb; 9(1):344-356. PubMed ID: 30187352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
    Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Miniaturized Measurement of Drug-Polymer Interactions via Viscosity Increase for Polymer Selection in Amorphous Solid Dispersions.
    Auch C; Harms M; Golitsyn Y; Reichert D; Mäder K
    Mol Pharm; 2019 May; 16(5):2214-2225. PubMed ID: 30920843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs.
    Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
    Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
    Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection.
    Schlauersbach J; Hanio S; Lenz B; Vemulapalli SPB; Griesinger C; Pöppler AC; Harlacher C; Galli B; Meinel L
    J Control Release; 2021 Feb; 330():36-48. PubMed ID: 33333120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    J Pharm Sci; 2011 Oct; 100(10):4349-56. PubMed ID: 21630280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
    Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
    Yeap YY; Trevaskis NL; Porter CJ
    Mol Pharm; 2013 Jul; 10(7):2601-15. PubMed ID: 23697606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relevance of supersaturation and solubilization in the gastrointestinal tract for oral bioavailability: An in vitro vs. in vivo approach.
    López Mármol Á; Denninger A; Touzet A; Dauer K; Becker T; Pöstges F; Pellequer Y; Lamprecht A; Wagner KG
    Int J Pharm; 2021 Jun; 603():120648. PubMed ID: 33915180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explicating the molecular level drug-polymer interactions at the interface of supersaturated solution of the model drug: Albendazole.
    Joshi P; Mallepogu P; Kaur H; Singh R; Sodhi I; Samal SK; Jena KC; Sangamwar AT
    Eur J Pharm Sci; 2021 Dec; 167():106014. PubMed ID: 34644598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.
    Machado TC; Kuminek G; Cardoso SG; Rodríguez-Hornedo N
    Eur J Pharm Sci; 2020 Sep; 152():105422. PubMed ID: 32531350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amorphous is not always better-A dissolution study on solid state forms of carbamazepine.
    Jensen LG; Skautrup FB; Müllertz A; Abrahamsson B; Rades T; Priemel PA
    Int J Pharm; 2017 Apr; 522(1-2):74-79. PubMed ID: 28263832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
    Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
    Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.